Interviews

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to engage diverse constituencies on the importance of the clinical trials process, regulatory review, and equitable access to COVID-19 vaccines.

Pharmacy Times® interviewed Sue Peschin, president and CEO of Alliance for Aging Research, on the work that the COVID-19 Vaccine Education and Equity Project is doing to support education about and equitable access to COVID-19 vaccines.

Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on how pharmacists can help people come back for the second dose of the COVID-19 vaccine.

Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on some of the challenges community pharmacies may need to manage when receiving and administering COVID-19 vaccines.

Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on the work needed to prepare for the arrival and administration of COVID-19 vaccines.

Pharmacy Times® interviewed Signe Pringle, the assistant secretary for the Maryland Department of Commerce, on a signed partnership between Quebec and Maryland to foster collaboration around health science research during COVID-19 and beyond.

In an interview with Pharmacy Times, Stefan Behrens, PhD, CEO and co-founder of GYANT, and Justin Graham, MD, MS, chief medical officer, said preparing patients for the process of receiving a coronavirus disease 2019 (COVID-19) vaccine is essential.

In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.

Pharmacy Times® interviewed Chad Landmon, JD, of Axinn, Veltrop & Harkrider, on the arguments presented to the Supreme Court on whether a legislative change to the Affordable Care Act makes the law unconstitutional.

In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said formulary adherence in health systems is essential for several reasons.

In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.

Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on the economic impact of the COVID-19 pandemic on small businesses, such as community pharmacies.

In a discussion with Pharmacy Times, Susan DiGregorio, BS Pharm, MS, RPh, director of clinical pharmacy development at Community Care Rx, said that collaborating with pediatricians and other health care providers is essential for pharmacists to effectively administer vaccines to children.

Pharmacy Times spoke with Michael Haydock, senior director of content for cardiovascular, metabolic, and infectious diseases at Informa Pharma Intelligence, about investigational therapeutics for COVID-19 and what’s in the pipeline.

Pharmacy Times® interviewed Amanda Epp, MBA, CEO of ScriptDrop, on how the COVID-19 pandemic has affected consumer behavior trends in the switch to digital prescription fulfillment.

Pharmacy Times® interviewed Petros Grivas, MD, PhD, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the work of the COVID-19 and Cancer Consortium.

Pharmacy Times® interviewed Rich Morino, senior director of health care solutions at LexisNexis, on how using social determinants of health in tandem with clinical data can benefit pharmacies.

Pharmacy Times® interviewed Amanda Epp, MBA, the CEO of ScriptDrop, on how granting provider status to pharmacists can allow them to better support the health care system in the fight against COVID-19.

Pharmacy students answered the question “Have you been able to build a professional pharmacy network during the pandemic?” The video is one part in the Pharmacy Times Student Café series.

Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on how federal and state law may affect vaccine administration in accordance with recent HHS declarations.

Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on how growth in the health care and biotech industry can support economic revitalization during and following the COVID-19 pandemic among community and retail pharmacies.

Pharmacy Times® interviewed John Beckner, RPh, the senior director of strategic initiatives at the NCPA, on the importance of American Pharmacists Month in acknowledging the critical role of pharmacists in supporting the US health care system.

Lennartz said it’s important that pharmacists are properly reimbursed for the administration of many common immunizations, including the flu vaccine.

Pharmacy Times® interviewed Petros Grivas, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the value of the pharmacist in the treatment of patients with cancer during COVID-19.

Many manufacturers are making headway in the race for a COVID-19 vaccine, with about 5 players in phase 3 trials.

Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on the value of the pharmacist during the flu season and concurrent COVID-19 pandemic this year.

In addition to caring for patients, leaders in pharmacy organizations have an opportunity to care for other employees, pharmacists, and technicians during the COVID-19 pandemic.

Collaborating with other health care providers is key, both to have the full picture of the patient’s health and to relay information back and forth.